<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William Howe, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert P Dellavalle, MD, PhD, MSPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph Fowler, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 31, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atopic dermatitis is a chronic, pruritic, inflammatory skin disease that occurs most frequently in children but also affects adults. Atopic dermatitis is often associated with an elevated serum level of immunoglobulin E (IgE) and a personal or family history of atopy, which describes a group of disorders that includes eczema, asthma, and allergic rhinitis [
         <a href="#rid1">
          1,2
         </a>
         ]. Although sensitization to environmental or food allergens is clearly associated with the atopic dermatitis phenotype, it does not seem to be a causative factor but may be a contributory factor in a subgroup of patients with severe disease [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5545.html" rel="external">
          "Role of allergy in atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
         The epidemiology, pathophysiology, clinical manifestations, and diagnosis of atopic dermatitis are reviewed here. The treatment of atopic dermatitis and the role of allergy in atopic dermatitis are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1726.html" rel="external">
          "Management of severe atopic dermatitis (eczema) in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/114004.html" rel="external">
          "Evaluation and management of severe refractory atopic dermatitis (eczema) in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5545.html" rel="external">
          "Role of allergy in atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H1079648957">
         <span class="h2">
          Prevalence and incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atopic dermatitis affects approximately 5 to over 20 percent of children worldwide, with large variations among countries and ethnic groups [
         <a href="#rid4">
          4,5
         </a>
         ]. Countries in Africa, Oceania, and the Asia-Pacific region have higher rates of atopic dermatitis than countries in the Indian subcontinent and Northern/Eastern Europe [
         <a href="#rid5">
          5
         </a>
         ]. In the United States, the overall prevalence is approximately 16 percent, with the highest rates reported in African American children (19 percent) [
         <a href="#rid6">
          6-9
         </a>
         ].
        </p>
        <p>
         Data on the prevalence of atopic dermatitis in adults are limited. Population-based studies from Scandinavian countries report prevalence rates of 10 to 14 percent among adults [
         <a href="#rid10">
          10-12
         </a>
         ]. In a United States, cross-sectional study including nearly 1300 adults, the prevalence of atopic dermatitis was 7.3 percent (95% CI 5.9-8.8) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         While the incidence remains high in urban areas and high-income countries, an increasing trend in incidence and prevalence of atopic eczema has been reported in the last few decades in Africa, East Asia, Western Europe, as well as in parts of Northern Europe [
         <a href="#rid5">
          5,14
         </a>
         ].
        </p>
        <p>
         In the vast majority of cases, atopic dermatitis has an onset before the age of five years, and prevalence data in children show a slight female preponderance [
         <a href="#rid15">
          15,16
         </a>
         ]. Persistent atopic dermatitis beyond infancy may affect approximately 50 percent of patients diagnosed with atopic dermatitis during childhood [
         <a href="#rid12">
          12,17
         </a>
         ]. Onset in the first six months of life appears to be associated with severe disease.
        </p>
        <p class="headingAnchor" id="H55133484">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Risk factors for atopic dermatitis include multiple genetic and environmental factors.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic risk factors
         </strong>
         – A family history of atopy (eczema, asthma, or allergic rhinitis) is the strongest risk factor for atopic dermatitis [
         <a href="#rid18">
          18
         </a>
         ]. Approximately 70 percent of patients have a positive family history of atopic diseases. Children with one atopic parent have a two- to threefold increased risk of developing atopic dermatitis, and the risk increases to three- to fivefold if both parents are atopic [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Loss-of-function variants in the
         <em>
          FLG
         </em>
         gene, resulting in defective epidermal barrier, are a major risk factor for atopic dermatitis and other skin and allergic diseases, including allergic contact dermatitis, asthma, and food allergy [
         <a href="#rid18">
          18-20
         </a>
         ]. Multiple other genes have been proposed as potential contributors to the risk of atopic dermatitis, including genes involved in the regulation of innate host defenses and T cell function [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="local">
          'Genetic factors'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Environmental exposures
         </strong>
         – Environmental factors, including climate, urban versus rural setting, air pollution, early exposure to nonpathogen microorganisms, and water hardness, may influence the risk of atopic dermatitis [
         <a href="#rid22">
          22,23
         </a>
         ]. Examples of studies linking environmental factors to atopic dermatitis are shown below:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          The "hygiene hypothesis"
         </strong>
         – Two systematic reviews provided evidence to support an inverse relationship between atopic dermatitis and exposure to endotoxin, early daycare, helminth infestation, number of siblings, farm animals, and pet dogs in early life [
         <a href="#rid24">
          24,25
         </a>
         ]. There was no protective effect associated with viral or bacterial infections.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Water hardness
         </strong>
         – Epidemiologic evidence from ecologic studies linked high hardness (high levels of
         <a class="drug drug_general" data-topicid="9185" href="/z/d/drug information/9185.html" rel="external">
          calcium carbonate
         </a>
         ) of domestic water with increased prevalence of atopic dermatitis in children [
         <a href="#rid26">
          26-31
         </a>
         ]. A 2021 meta-analysis of seven observational studies that included nearly 386,000 participants found a modest increase of risk of atopic dermatitis in children exposed to hard water (odds ratio [OR] 1.28, 95% CI 1.09-1.50) [
         <a href="#rid31">
          31
         </a>
         ]. However, the authors considered the certainty of this estimate to be very low, due to high risk of bias and heterogeneity in the definition of "hard water."
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         A multiplicity of mechanisms are involved in the pathogenesis of atopic dermatitis, including epidermal barrier dysfunction, genetic factors, Th2 cell-skewed immune dysregulation, altered skin microbiome, and environmental triggers of inflammation [
         <a href="#rid32">
          32-36
         </a>
         ]. Whether skin inflammation is initiated by skin barrier dysfunction ("outside-in" hypothesis) or by immune dysregulation ("inside-out" hypothesis) is still debated. It is increasingly recognized that combinations of different mechanisms result in multiple "endotypes" and phenotypes of atopic dermatitis [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Epidermal barrier dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The epidermal barrier function primarily resides in the stratum corneum, which consists of vertical stacks of anucleate corneocytes packed with keratin filaments embedded in a matrix of filaggrin breakdown products, ceramides, cholesterol, and free fatty acids [
         <a href="#rid37">
          37,38
         </a>
         ]. The stratum corneum provides the first line of defense against the environment, including pathogens and allergens, and controls water homeostasis. An altered stratum corneum, therefore, results in increased transepidermal water loss, increased permeability, reduced water retention, and altered lipid composition [
         <a href="#rid39">
          39-41
         </a>
         ].
        </p>
        <p>
         Epidermal barrier dysfunction is the key abnormality in the pathophysiology of atopic dermatitis [
         <a href="#rid41">
          41
         </a>
         ], hence the importance of moisturizers and emollients in the management of atopic dermatitis. (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)", section on 'Emollients and moisturizers'
         </a>
         .)
        </p>
        <p>
         Epidermal barrier dysfunction is caused by multiple factors, including reduced filaggrin production, imbalance between stratum corneum protease and antiprotease activity, tight junction abnormalities, altered composition and lamellar organization of epidermal lipids, microbial colonization, itch-scratch cycle, and release of proinflammatory cytokines.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Filaggrin
         </strong>
         – Filaggrin deficiency is a major determinant of defective barrier function [
         <a href="#rid18">
          18
         </a>
         ]. It is associated with disruption of keratinocyte differentiation, impaired corneocyte integrity and cohesion, impaired tight junction formation, decreased water retention, altered lipid formation, and enhanced susceptibility to cutaneous infection. The filaggrin precursor profilaggrin is encoded by the
         <em>
          FLG
         </em>
         gene, located in the epidermal differentiation complex on chromosome 1q21.3. Following its synthesis, profilaggrin undergoes extensive phosphorylation, is stored in keratohyalin granules, and, subsequently, dephosphorylated and cleaved by several endoproteases into filaggrin monomers that have keratin-filament-aggregating properties [
         <a href="#rid42">
          42,43
         </a>
         ]. Further degradation of filaggrin monomers in the upper stratum corneum releases hygroscopic amino acids and their derivatives (eg, pyrrolidone carboxylic acid, trans-urocanic acid) that, together with sodium and chloride ions, urea, and lactate, compose the natural moisturizing factor (NMF) [
         <a href="#rid44">
          44
         </a>
         ]. NMF maintains skin hydration and water retention within the stratum corneum in conditions of low environmental humidity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other factors that can result in skin barrier breakdown include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Imbalance between stratum corneum protease (eg, kallikrein, stratum corneum chymotryptic enzyme) and antiprotease activity (eg, lymphoepithelial Kazal-type related inhibitor [LEKTI]).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormalities of the tight junction function. Tight junctions are located in the granular layer of the epidermis below the stratum corneum and are thought to seal the intercellular space to prevent the free diffusion of macromolecules [
         <a href="#rid45">
          45
         </a>
         ]. Defective tight junctions may contribute to skin barrier impairment. Tight junctions are composed of a number of transmembrane proteins, such as proteins of the claudin family, junctional adhesion molecule (JAM)-A, occludin, and tricellulin. A reduced expression of the tight junction protein claudin-1 has been demonstrated in nonlesional skin of individuals with atopic dermatitis [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Microbial colonization and release of proinflammatory cytokines [
         <a href="#rid47">
          47
         </a>
         ]. (See
         <a class="local">
          'Alteration of cutaneous microbiome'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory cytokines, such as interleukin (IL) 4, IL-13, IL-17A, IL- 22, IL-25, and IL-31, have also been shown to suppress filaggrin expression in the skin, resulting in additional barrier impairment [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14448090">
         <span class="h2">
          Genetic factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         A genetic basis for atopic dermatitis was initially suggested by twin studies that found concordance rates of 80 percent for monozygotic twins compared with 20 percent for dizygotic twins [
         <a href="#rid49">
          49-51
         </a>
         ]. Subsequently, multiple linkage studies and genome-wide association studies (GWAS) implicated loci associated with skin barrier abnormalities, in particular the epidermal differentiation complex on chromosome 1q21, which includes
         <em>
          FLG
         </em>
         , and new loci, including candidate genes involved in the regulation of innate host defenses and T cell function [
         <a href="#rid20">
          20,21,52
         </a>
         ]. However, these genetic susceptibility loci account for less than 20 percent of the total heritability of atopic dermatitis, with most of it remaining largely unexplained [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2768484049">
         <span class="h3">
          FLG variants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Loss-of-function variants in
         <em>
          FLG
         </em>
         , located in the epidermal differentiation complex on chromosome 1q21.3 and encoding profilaggrin, cause ichthyosis vulgaris [
         <a href="#rid53">
          53
         </a>
         ], the most common single-gene, inherited disorder of keratinization (see
         <a class="medical medical_review" href="/z/d/html/15471.html" rel="external">
          "Ichthyosis vulgaris"
         </a>
         ), and are also the strongest genetic risk factor for atopic dermatitis [
         <a href="#rid52">
          52
         </a>
         ]. In meta-analyses, loss-of-function variants in
         <em>
          FLG
         </em>
         are associated with a three- to fourfold increased risk of atopic dermatitis [
         <a href="#rid19">
          19,20,54
         </a>
         ].
        </p>
        <p>
         The prevalence of loss-of-function
         <em>
          FLG
         </em>
         variants in patients with atopic dermatitis varies among geographic areas and ethnic groups. Prevalence rates of up to 50 and 27 percent have been reported in patients of European and Asian descent, respectively. In contrast, loss-of-function variants in
         <em>
          FLG
         </em>
         appear to be uncommon in African patients with atopic dermatitis, with prevalence rates of &lt;1 percent [
         <a href="#rid55">
          55-57
         </a>
         ].
         <em>
          FLG
         </em>
         variants appear to be relatively higher among African American patients. In a United States cohort of 741 children from the Pediatric Eczema Elective Registry (PEER), the prevalence of any
         <em>
          FLG
         </em>
         variants was 31.5 percent in White children and 15.3 percent in African American children [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         The prevalence of specific
         <em>
          FLG
         </em>
         variants also varies across different populations. The most prevalent variants are R501X, 2282del4, S3247X, and R2447X in European patients; S2889X in patients from the Indian subcontinent; 3321delA in East Asian patients; K4022X in Korean and Northern Chinese patients; and S2554X, S2889X, S3296X, and Q1701X in Japanese patients [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         <em>
          FLG
         </em>
         variants are associated with specific atopic dermatitis phenotypes, including early-onset and persistent disease; increased risk of asthma, allergic rhinitis, and food allergy; increased prevalence and persistence of hand and foot dermatitis during adulthood; and multiple contact allergies [
         <a href="#rid60">
          60-64
         </a>
         ]. The
         <em>
          FLG
         </em>
         genotype may also influence the response to treatment. In a cohort study of 842 children enrolled in the PEER and followed up for an average of 7.6 years, patients with homozygous, loss-of-function
         <em>
          FLG
         </em>
         variants were less likely to report any period of skin clearance and more likely to report frequent steroid use than patients with wild-type
         <em>
          FLG
         </em>
         or heterozygous
         <em>
          FLG
         </em>
         variants [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3865686887">
         <span class="h3">
          Other genes
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to
         <em>
          FLG
         </em>
         , other potential susceptibility genes for atopic dermatitis have been found, including genes involved in the regulation of innate host defenses and T cell functions [
         <a href="#rid66">
          66,67
         </a>
         ]. A meta-analysis of 26 GWAS that included over 21,000 cases and 95,000 controls found 31 loci associated with atopic dermatitis [
         <a href="#rid21">
          21
         </a>
         ]. These comprised widely replicated loci, such as the epidermal differentiation complex on 1q21.3 (including
         <em>
          FLG
         </em>
         ); the cytokine cluster on 5q31.1 (including genes encoding IL-13 and IL-4); the locus on chromosome 11q13.5, between two candidate genes,
         <em>
          EMSY
         </em>
         and
         <em>
          LRRC32
         </em>
         ; as well as new loci, including candidate genes involved in the regulation of innate host defenses and T cell function.
        </p>
        <p class="headingAnchor" id="H79161793">
         <span class="h2">
          Immune dysregulation and inflammation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both the innate and acquired immune responses have a role in the pathogenesis of type 2 inflammation in atopic dermatitis [
         <a href="#rid32">
          32,68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13572.html" rel="external">
          "An overview of the innate immune system"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3980.html" rel="external">
          "The adaptive cellular immune response: T cells and cytokines"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3975.html" rel="external">
          "The adaptive humoral immune response"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5545.html" rel="external">
          "Role of allergy in atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
         Keratinocytes and antigen-presenting cells in the skin express a number of innate immune receptors called pattern recognition receptors, which include toll-like receptors (TLRs). Stimulation of TLRs by tissue damage or microorganisms leads to the release of a wide range of danger signals (alarmins), including antimicrobial peptides (AMPs); cytokines, such as IL-1A, thymic stromal lymphopoietin (TSLP), IL-25, and IL-33; proteases (kallikreins, cathepsins); and extracellular matrix (ECM) proteins, such as periostin [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         The release of alarmins triggered by epithelial barrier disruption activates inflammatory dendritic epidermal cells and type 2 immune cells, including Th2 cells, skin-resident group 2 innate lymphoid cells (ILC2s), mast cells, and basophils. Activated Th2 cells release IL-4 and IL-13, which promote inflammation as well as B cell IgE class switching, the latter resulting in the production of antigen-specific IgE molecules via the signal transducer and activator of transcription (STAT) pathway [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         In addition to their role in promoting inflammation, Th2 cytokines (IL-4, IL-13, IL-31, and IL-22) affect the epidermal barrier function by suppressing the expression of terminal keratinocyte differentiation genes (eg,
         <em>
          FLG
         </em>
         , loricrin, involucrin), inhibiting the production of AMPs, and promoting epidermal hyperplasia [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3498822478">
         <span class="h2">
          Neuroimmune interactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic itch is a defining symptom of atopic dermatitis. Itch is mediated by the transmission of signals along unmyelinated, histamine-sensitive and non-histamine-sensitive peripheral C-nerve fibers that originate from cell bodies of primary sensory neurons (pruriceptors) located in the dorsal root ganglia [
         <a href="#rid71">
          71
         </a>
         ]. The nerve endings in the epidermis, papillary dermis, and skin appendages are activated by endogenous and exogenous pruritogens, including histamine, cytokines, and proteases and their respective receptors. (See
         <a class="medical medical_review" href="/z/d/html/16589.html" rel="external">
          "Pruritus: Etiology and patient evaluation"
         </a>
         .)
        </p>
        <p>
         In atopic dermatitis, chronic itch results from complex interactions among non-histamine-sensitive peripheral C-nerve fibers, keratinocytes, and Th2 immune cells. Type 2 cytokines, including IL-4, IL-13, TSLP, and IL-31, are thought to be relevant mediators of chronic itch in atopic dermatitis. In mouse models, sensory neurons that innervate the skin were found to express IL-4, IL-13, and IL-31 receptors [
         <a href="#rid72">
          72
         </a>
         ]. Although, in these models, IL-4 did not directly trigger itch, it sensitized dorsal root ganglia neurons to a variety of pruritogens, eliciting an itch response to otherwise subthreshold amounts of pruritogens. The responsiveness of itch to inhibition of the IL-4 receptor (
         <a class="drug drug_general" data-topicid="112484" href="/z/d/drug information/112484.html" rel="external">
          dupilumab
         </a>
         ) and downstream IL-4 signaling (Janus kinase [JAK] inhibitors) supports the relevance of these neuroimmune interactions in the pathogenesis of chronic atopic itch [
         <a href="#rid73">
          73,74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)", section on 'Controlling pruritus'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2003694555">
         <span class="h2">
          Alteration of cutaneous microbiome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with atopic dermatitis have substantial alteration of the skin microbiome, characterized by reduced diversity of the bacterial community and overgrowth of
         <em>
          Staphylococcus aureus
         </em>
         , especially in lesional skin [
         <a href="#rid75">
          75
         </a>
         ]. A meta-analysis of 95 observational studies found that 70 percent of patients with atopic dermatitis carried
         <em>
          S. aureus
         </em>
         on lesional skin (95% CI 66-74), and 39 percent carried
         <em>
          S. aureus
         </em>
         on nonlesional skin (95% CI 31-47) [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         A skin microbiome study using high-throughput DNA sequencing of the bacterial 16S rRNA gene in patients with moderate to severe atopic dermatitis and healthy controls found a striking decrease in the skin microbial diversity during flares, with reduction of
         <em>
          Streptococcus
         </em>
         ,
         <em>
          Corynebacterium
         </em>
         , and
         <em>
          Propionibacterium
         </em>
         genera and increase in
         <em>
          S. aureus
         </em>
         density [
         <a href="#rid77">
          77
         </a>
         ]. Of note, the microbiome diversity reverted to normal after treatment.
        </p>
        <p>
         A multiplicity of bacterial proteins that act as virulence factors, including clumping factor B, fibronectin-binding proteins, proinflammatory proteins, toxins, enterotoxins, and proteases, contribute to the pathogenesis of atopic dermatitis [
         <a href="#rid75">
          75
         </a>
         ]. Toxic shock syndrome toxin-1 (TSST-1) and the staphylococcal enterotoxin serotypes SEA, SEB, SEC, SED, SEE, or SEG are superantigens that bind to major histocompatibility class II (MHCII) molecules on the surface of antigen-presenting cells and T cell receptors on T cells, resulting in excessive production of T cell cytokines. Moreover, superantigens are also allergens that can elicit an IgE response and trigger mast cell degranulation [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H98844203">
         <span class="h1">
          PATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Histologically, atopic dermatitis is characterized by epidermal changes, including spongiosis (epidermal edema), with varying degrees of acanthosis and hyperkeratosis, accompanied by a lymphohistiocytic infiltrate in the dermis. In the acute phase, the histologic picture is dominated by spongiosis, an intercellular epidermal edema that leads to stretching and eventual rupture of the intercellular attachments, with the formation of vesicles.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1974708121">
         <span class="h2">
          Common features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dry skin and severe pruritus are the cardinal signs of atopic dermatitis. However, the clinical presentation is highly variable, depending upon the patient's age, ethnicity, and disease activity  (
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Acute eczema is characterized by intensely pruritic, erythematous papules and vesicles with exudation and crusting  (
         <a class="graphic graphic_picture graphicRef56461" href="/z/d/graphic/56461.html" rel="external">
          picture 4B
         </a>
         ), whereas subacute or chronic lesions present as dry, scaly, or excoriated, erythematous papules  (
         <a class="graphic graphic_picture graphicRef55424" href="/z/d/graphic/55424.html" rel="external">
          picture 6C
         </a>
         ). Skin thickening from chronic scratching (lichenification) and fissuring may develop over time  (
         <a class="graphic graphic_picture graphicRef68215" href="/z/d/graphic/68215.html" rel="external">
          picture 1A
         </a>
         ). In many patients, lesions in different stages may be present at the same time.
        </p>
        <p>
         In children and adults with deeply pigmented skin, erythema may appear dark brown or violaceous instead of pink or red, as typically seen in patients with lighter complexions. The typical erythematous and scaly lesions of eczema may appear as lesions with a grayish, violaceous, or dark brown hue  (
         <a class="graphic graphic_picture graphicRef68215 graphicRef102395 graphicRef56815" href="/z/d/graphic/68215.html" rel="external">
          picture 1A-C
         </a>
         ). Dry skin may have a whitish or ashy color and a reduction in skin shininess  (
         <a class="graphic graphic_picture graphicRef101381" href="/z/d/graphic/101381.html" rel="external">
          picture 2
         </a>
         ). Lichenified areas typically appear hyperpigmented  (
         <a class="graphic graphic_picture graphicRef68215 graphicRef64525" href="/z/d/graphic/68215.html" rel="external">
          picture 1A, 1D
         </a>
         ). Postinflammatory hyper- and hypopigmentation are also common  (
         <a class="graphic graphic_picture graphicRef116283 graphicRef116284" href="/z/d/graphic/116283.html" rel="external">
          picture 3A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/95847.html" rel="external">
          "Postinflammatory hyperpigmentation"
         </a>
         .)
        </p>
        <p>
         Atopic dermatitis occurs in the first year of life in 60 percent of cases and by the age of five years in nearly 85 percent of cases. The clinical presentation at various ages is outlined below [
         <a href="#rid78">
          78
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In infants and young children (zero to two years), atopic dermatitis typically presents with pruritic, red, scaly, and crusted lesions on the extensor surfaces and cheeks or scalp  (
         <a class="graphic graphic_picture graphicRef77457 graphicRef56461 graphicRef77386 graphicRef116268 graphicRef116269" href="/z/d/graphic/77457.html" rel="external">
          picture 4A-E
         </a>
         ) but may be diffuse  (
         <a class="graphic graphic_picture graphicRef116270 graphicRef77457" href="/z/d/graphic/116270.html" rel="external">
          picture 4A, 4F
         </a>
         ). There is usually sparing of the diaper area  (
         <a class="graphic graphic_picture graphicRef68746" href="/z/d/graphic/68746.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid78">
          78
         </a>
         ]. Acute lesions can include vesicles, and there can be serous exudates and crusting in severe cases.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In older children and adolescents (2 to 16 years), atopic dermatitis is characterized by less exudation and often demonstrates lichenified plaques in a flexural distribution, especially of the antecubital and popliteal fossae, volar aspect of the wrists, ankles, and neck  (
         <a class="graphic graphic_picture graphicRef68215 graphicRef65407 graphicRef52163" href="/z/d/graphic/68215.html" rel="external">
          picture 1A, 1E-F
         </a>
         ) [
         <a href="#rid78">
          78
         </a>
         ]. The sides of the neck may show a reticulate pigmentation, the so-called "atopic dirty neck"  (
         <a class="graphic graphic_picture graphicRef102395 graphicRef116284" href="/z/d/graphic/102395.html" rel="external">
          picture 1B, 3B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In adults, atopic dermatitis is considerably more localized and lichenified. The areas involved are, in most cases, the skin flexures  (
         <a class="graphic graphic_picture graphicRef116281 graphicRef64525 graphicRef55375 graphicRef116286 graphicRef116283" href="/z/d/graphic/116281.html" rel="external">
          picture 1D, 1G-I, 3A
         </a>
         ). Less frequently, the dermatitis may involve the face, neck  (
         <a class="graphic graphic_picture graphicRef116284 graphicRef102395" href="/z/d/graphic/116284.html" rel="external">
          picture 1B, 3B
         </a>
         ), or hands  (
         <a class="graphic graphic_picture graphicRef82881 graphicRef116272" href="/z/d/graphic/82881.html" rel="external">
          picture 6A-B
         </a>
         ) [
         <a href="#rid78">
          78,79
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In all age groups, any area of the body can be involved in severe cases, although it is uncommon to see lesions in the axillary, gluteal, or groin area. Lesions in these locations should prompt consideration of other diagnoses, such as psoriasis, allergic contact dermatitis, or seborrheic dermatitis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H43807123">
         <span class="h2">
          Associated features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with atopic dermatitis may present a variety of cutaneous findings, so-called "atopic stigmata," which include [
         <a href="#rid80">
          80
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Centrofacial pallor
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         White dermographism
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Keratosis pilaris  (
         <a class="graphic graphic_picture graphicRef60786 graphicRef68488" href="/z/d/graphic/60786.html" rel="external">
          picture 7A-B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Palmar hyperlinearity  (
         <a class="graphic graphic_picture graphicRef116440" href="/z/d/graphic/116440.html" rel="external">
          picture 14B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pityriasis alba  (
         <a class="graphic graphic_picture graphicRef60866" href="/z/d/graphic/60866.html" rel="external">
          picture 8
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Periorbital darkening ("allergic shiners") and Dennie-Morgan infraorbital folds  (
         <a class="graphic graphic_picture graphicRef116441 graphicRef116438 graphicRef62145 graphicRef122215" href="/z/d/graphic/116441.html" rel="external">
          picture 9A-D
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thinning or absence of the lateral portion of the eyebrows (Hertoghe's sign)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infra-auricular and retroauricular fissuring
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nipple eczema
        </p>
        <p>
        </p>
        <p>
         Although considered minor diagnostic criteria, these findings are frequently seen and may be supportive of the diagnosis of atopic dermatitis in some patients  (
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3942787364">
         <span class="h2">
          Clinical variants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional and morphologic variants of atopic dermatitis have been described in both children and adults [
         <a href="#rid80">
          80,81
         </a>
         ]. They may be the only manifestation of atopic dermatitis or occur in association with the classic age-related manifestations. Regional variants include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atopic hand eczema
         </strong>
         – Atopic hand eczema typically involves the volar wrists and dorsum of the hands  (
         <a class="graphic graphic_picture graphicRef82881 graphicRef55424 graphicRef116272" href="/z/d/graphic/82881.html" rel="external">
          picture 6A-C
         </a>
         ). It is most common in adults with a history of atopic dermatitis who no longer have dermatitis in typical areas (eg, flexural), especially in those who are exposed to "wet work" environments [
         <a href="#rid82">
          82
         </a>
         ]. Concurrent foot eczema has been reported in approximately one-third of patients with atopic hand eczema [
         <a href="#rid83">
          83
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13658.html" rel="external">
          "Chronic hand eczema"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Eyelid eczema
         </strong>
         – Eyelid dermatitis is a common feature of atopic dermatitis and, in some patients, may be the only manifestation  (
         <a class="graphic graphic_picture graphicRef116274 graphicRef122214 graphicRef122469 graphicRef116273" href="/z/d/graphic/116274.html" rel="external">
          picture 10A-D
         </a>
         ) [
         <a href="#rid84">
          84
         </a>
         ]. It is often associated with lichenification and presence of Dennie-Morgan lines  (
         <a class="graphic graphic_picture graphicRef116438 graphicRef62145 graphicRef122215" href="/z/d/graphic/116438.html" rel="external">
          picture 9B-D
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/120320.html" rel="external">
          "Eyelid dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atopic cheilitis
         </strong>
         – Lip eczema or "cheilitis sicca" is a common manifestation of atopic dermatitis, characterized by dryness, peeling, and fissuring of the lips  (
         <a class="graphic graphic_picture graphicRef91322" href="/z/d/graphic/91322.html" rel="external">
          picture 11
         </a>
         ). The clinical appearance may be indistinguishable from irritant or allergic cheilitis. (See
         <a class="medical medical_review" href="/z/d/html/13654.html" rel="external">
          "Cheilitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Morphologic variants include nummular, prurigo nodularis-type, and follicular-type atopic dermatitis [
         <a href="#rid81">
          81,85
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13666.html" rel="external">
          "Nummular eczema"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13667.html" rel="external">
          "Prurigo nodularis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3517015751">
         <span class="h2">
          Laboratory findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Up to 80 percent of patients with atopic dermatitis have increased serum IgE levels, often with eosinophilia. The IgE level tends to vary with disease severity, although some patients with severe disease have normal IgE values.
        </p>
        <p>
         Most patients with atopic dermatitis have a cutaneous hyperreactivity to various environmental stimuli, including exposure to food and inhalant allergens, irritants, changes in physical environment (including pollution, humidity, etc), microbial infection, and stress [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4291280">
         <span class="h2">
          Clinical course and complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atopic dermatitis follows a chronic, relapsing course over months to years. Patients with mild disease may experience intermittent flares with spontaneous remission, but patients with moderate to severe dermatitis rarely clear without treatment.
        </p>
        <p>
         The majority of patients are clear of eczema by late childhood, but the disease may persist into adolescence and adulthood in a variable proportion of cases [
         <a href="#rid10">
          10,12,86-89
         </a>
         ].
        </p>
        <p>
         A pooled analysis of 45 studies including over 110,000 subjects found that 20 percent of cases of childhood atopic dermatitis had persistent disease eight years after the diagnosis and less than 5 percent had persistent disease 20 years after the diagnosis [
         <a href="#rid90">
          90
         </a>
         ]. The age of onset was the main factor associated with persistence of atopic dermatitis. The hazard ratio was 2.65 (95% CI 2.54-2.75) for onset at age 2 to 5 years, 4.22 (95% CI 3.86-4.61) for onset at age 6 to 11 years, and 2.04 (95% CI 1.66-2.49) for onset at age 12 to 17 years compared with age of onset &lt;2 years. Other risk factors for persistence were disease severity and duration and female sex. Hypersensitivity to one or more allergens did not seem to influence the persistence of atopic dermatitis.
        </p>
        <p>
         Patients with atopic dermatitis are predisposed to the development of bacterial and viral skin infections. Because
         <em>
          S. aureus
         </em>
         colonizes nearly 100 percent of patients, impetiginization of lesions of atopic dermatitis is frequent and is associated with disease exacerbation. However, infection from community-acquired, methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) is uncommon among children with atopic dermatitis [
         <a href="#rid91">
          91-93
         </a>
         ].
        </p>
        <p>
         Eczema herpeticum, also called Kaposi's varicelliform eruption, is the rapid dissemination of a herpes simplex viral infection on the affected skin of patients with atopic dermatitis  (
         <a class="graphic graphic_picture graphicRef64142 graphicRef74838 graphicRef51337" href="/z/d/graphic/64142.html" rel="external">
          picture 12A-C
         </a>
         ). Eczema herpeticum is a rare complication, occurring in less than 3 percent of patients with atopic dermatitis, and can occasionally be recurrent [
         <a href="#rid94">
          94
         </a>
         ]. Severe eczema, high levels of serum IgE, and history of food allergy or asthma appear to be predisposing factors [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
         In children with atopic dermatitis, atypical hand, foot, and mouth disease (HFMD; caused by coxsackievirus A6) lesions tend to appear in areas previously or currently affected by the dermatitis, similar to eczema herpeticum ("eczema coxsackium")  (
         <a class="graphic graphic_picture graphicRef103799" href="/z/d/graphic/103799.html" rel="external">
          picture 13
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13739.html" rel="external">
          "Atypical exanthems in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H80247225">
         <span class="h1">
          COMORBIDITIES
         </span>
        </p>
        <p class="headingAnchor" id="H86702391">
         <span class="h2">
          Allergic rhinitis, asthma, and food allergy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with atopic dermatitis and a genetic predisposition to produce IgE following exposure to allergens may develop a typical sequence of atopic dermatitis, allergic rhinitis, asthma, and food allergy at certain ages (the "atopic march") [
         <a href="#rid1">
          1,96,97
         </a>
         ]. Patients with atopic dermatitis also have an increased risk of food-induced urticaria/anaphylaxis [
         <a href="#rid98">
          98,99
         </a>
         ], eosinophilic esophagitis, and chronic rhinosinusitis/nasal polyps [
         <a href="#rid100">
          100
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5545.html" rel="external">
          "Role of allergy in atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p>
         Although the rate of food sensitization is high in infants and young children, ranging from approximately 30 to 60 percent depending upon the population and diagnostic test, the actual rate of confirmed food allergy is much lower [
         <a href="#rid98">
          98,101-105
         </a>
         ]. Therefore, serum IgE should
         <strong>
          not
         </strong>
         be used for the diagnosis of food allergy in the absence of clinical reactions to the ingestion of a certain food. (See
         <a class="medical medical_review" href="/z/d/html/5745.html" rel="external">
          "Food allergy in children: Prevalence, natural history, and monitoring for resolution"
         </a>
         .)
        </p>
        <p>
         Multiple studies indicated that the risk of progression to atopic march is inversely associated with the age of onset of atopic dermatitis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A cohort study including nearly 4000 children with at least three years of follow-up found that the cumulative incidence of seasonal allergies and asthma during the follow-up was higher among children with atopic dermatitis onset before age 2 than among those with onset at ages 3 to 7 or 8 to 17 (39, 32, and 30 percent, respectively) [
         <a href="#rid106">
          106
         </a>
         ]. However, since the age at onset was self-reported, a misclassification bias cannot be excluded.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a Canadian cohort of 2311 children with atopic dermatitis, allergic sensitization detected by skin prick testing at age one year was associated with a sevenfold increased risk of asthma at age three compared with absence of allergic sensitization (relative risk [RR] 7.04, 95% CI 4.13-11.99) [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Whether there is a cause-effect relationship between atopic dermatitis and subsequent development of type 2 inflammatory comorbidities is still debated.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epicutaneous sensitization to environmental allergens
         </strong>
         –
         <strong>
         </strong>
         It has been hypothesized that epicutaneous sensitization to allergens, including food allergens, can occur in early life in children with atopic dermatitis due to the defective skin barrier, therefore increasing the risk of other forms of allergic disease during childhood [
         <a href="#rid108">
          108-111
         </a>
         ]. In one study of 512 children younger than 15 months with a history of atopic dermatitis, exposure to peanut antigen in household dust was associated with a twofold increased risk of peanut sensitization and peanut allergy [
         <a href="#rid112">
          112
         </a>
         ]. Several trials are underway to evaluate whether the enhancement of a defective skin barrier with daily application of emollients during the first months of life, which has been shown to halve the incidence of atopic dermatitis in infants, also reduces the risk of early allergic sensitization and, therefore, the incidence of respiratory or food allergy later in life [
         <a href="#rid113">
          113-115
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)", section on 'Skin barrier enhancement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          IgE autoreactivity
         </strong>
         –
         <strong>
         </strong>
         IgE autoantibodies directed against keratinocyte proteins, which have been detected in approximately 15 percent of patients with atopic dermatitis, may have a role in the development of type 2 inflammatory comorbidities [
         <a href="#rid116">
          116
         </a>
         ]. It is unclear if the development of IgE autoantibodies results from exposure to environmental antigens (through the defective skin barrier) or to autoantigens released as a result of skin inflammation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H55134481">
         <span class="h2">
          Ichthyosis vulgaris
         </span>
         <span class="headingEndMark">
          —
         </span>
         Loss-of-function variants in the filaggrin gene (
         <em>
          FLG
         </em>
         ), which causes ichthyosis vulgaris, confer an increased risk of developing atopic dermatitis and are associated with early-onset, moderate to severe, and persistent eczema [
         <a href="#rid19">
          19,52,117
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15471.html" rel="external">
          "Ichthyosis vulgaris"
         </a>
         .)
        </p>
        <p>
         It is estimated that approximately 10 to 30 percent of patients with atopic dermatitis also have ichthyosis vulgaris [
         <a href="#rid118">
          118,119
         </a>
         ]. These patients usually show palmar hyperlinearity  (
         <a class="graphic graphic_picture graphicRef90481 graphicRef116440" href="/z/d/graphic/90481.html" rel="external">
          picture 14A-B
         </a>
         ) and keratosis pilaris  (
         <a class="graphic graphic_picture graphicRef68488 graphicRef60786" href="/z/d/graphic/68488.html" rel="external">
          picture 7A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15465.html" rel="external">
          "Overview and classification of the inherited ichthyoses", section on 'Ichthyosis vulgaris'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13663.html" rel="external">
          "Keratosis pilaris"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4291555">
         <span class="h2">
          Eye diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ocular comorbidities occurring in patients with atopic dermatitis include atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC). AKC is a chronic, allergic, ocular disease that most often occurs in adults with a history of atopic dermatitis [
         <a href="#rid120">
          120
         </a>
         ]. VKC most commonly occurs in children living in warm, dry, subtropical climates [
         <a href="#rid121">
          121
         </a>
         ]. Ocular itching, burning, tearing, and mucus discharge are common symptoms. Complications include keratoconus, infectious keratitis, and blepharitis. (See
         <a class="medical medical_review" href="/z/d/html/5550.html" rel="external">
          "Atopic keratoconjunctivitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5549.html" rel="external">
          "Vernal keratoconjunctivitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1182241646">
         <span class="h2">
          Psychiatric disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is a growing body of evidence that a number of psychiatric disorders and symptoms, including impaired psychosocial functioning, attention deficit hyperactivity disorder (ADHD), learning disability, depression, and anxiety disorders, are more common among adults and children with atopic dermatitis than in the general population [
         <a href="#rid122">
          122-125
         </a>
         ]. The association of atopic dermatitis with psychosocial distress and other psychiatric disorders may be influenced by the perceived disease severity and other factors that negatively affect quality of life, such as the loss of sleep, disabling pruritus, social embarrassment, and impaired social functioning [
         <a href="#rid123">
          123,126
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3695700797">
         <span class="h3">
          Attention deficit hyperactivity disorder
         </span>
         <span class="headingEndMark">
          —
         </span>
         The results of a 2010 systematic review of 20 studies including over 170,000 individuals and several subsequent, observational studies suggest an association between atopic dermatitis and attention deficit hyperactivity disorder (ADHD) in children as well as in adults [
         <a href="#rid122">
          122,127-131
         </a>
         ]. The mechanisms underlying ADHD and atopic dermatitis are unknown. Sleep disturbance secondary to nocturnal pruritus, elevated levels of psychologic stress, and the effects of proinflammatory cytokines on brain development are the leading hypotheses to explain this association [
         <a href="#rid130">
          130,132,133
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/624.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">
          "Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/602.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2381976672">
         <span class="h3">
          Depression and anxiety disorder
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several cohort studies and meta-analyses have found an association between atopic dermatitis and anxiety disorder, depression, suicidal ideation, and attempted suicide in adults and children [
         <a href="#rid122">
          122,134-139
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An analysis of data on over 90,000 children from the 2007 National Survey of Children's Health in the United States found that among children with atopic dermatitis, the prevalence of depression and anxiety disorders was significantly higher than among their peers without atopic dermatitis (6.5 versus 3.4 percent, and 7.3 versus 4.1 percent, respectively) and showed an increasing trend with increasing parent- and caregiver-reported severity of dermatitis [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A large, longitudinal, cohort study using data from the Taiwan National Health Insurance Research Database from 1998 to 2008 assessed the risk of developing major depression or anxiety disorders later in life among more than 8000 adolescents and adults with atopic dermatitis and age- and sex-matched controls [
         <a href="#rid134">
          134
         </a>
         ]. This study found that patients with atopic dermatitis had an increased risk of developing major depression (hazard ratio [HR] 6.56, 95% CI 3.64-11.84), any depressive disorder (HR 5.44, 95% CI 3.99-7.44), and anxiety disorders (HR 3.57, 95% CI 2.55-4.98).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2019 meta-analysis of 37 observational studies found a nearly twofold increased risk of depression in patients with atopic dermatitis compared with individuals without atopic dermatitis (odds ratio [OR] 1.71, 95% CI 1.48-1.98). Based on data from 14 studies, patients with atopic dermatitis were also more likely to have suicidal ideation (OR 1.97, 95% CI 1.19-3.25) [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The association between atopic dermatitis and suicidality was examined in another meta-analysis of 15 observational studies including over 310,000 patients with atopic dermatitis and nearly 4.5 million controls [
         <a href="#rid137">
          137
         </a>
         ]. Compared with persons without atopic dermatitis, patients with atopic dermatitis were found to have an increased risk of suicidal ideation (pooled OR 1.44, 95% CI 1.25-1.65) and suicide attempts (pooled OR 1.36, 95% CI 1.09-1.70). Two of the included studies reporting on the risk of completed suicide among patients with atopic dermatitis provided conflicting results [
         <a href="#rid140">
          140,141
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The results of these studies emphasize the need for a multidisciplinary approach to the management of atopic dermatitis that includes patient and parent/caregiver education and psychologic and behavioral support (see
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)"
         </a>
         ). Clinicians treating atopic dermatitis should be vigilant for depressive symptoms, especially in patients with severe disease who may need psychiatric referral.
        </p>
        <p class="headingAnchor" id="H86702411">
         <span class="h2">
          Obesity and metabolic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The association between atopic dermatitis and obesity in children and adults is controversial [
         <a href="#rid142">
          142-146
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2022 pooled analysis of eight cross-sectional studies found a modest association between atopic dermatitis and obesity (OR 1.36, 95% CI 1.01-1.83) and a weak association with hypercholesterolemia (OR 1.13, 95% CI 1.09-1.18) [
         <a href="#rid147">
          147
         </a>
         ]. The study also found that atopic dermatitis was associated with a slightly lower risk of type 2 diabetes (OR 0.83, 95% CI 0.76-0.90).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2015 systematic review and meta-analysis of 30 observational studies found that being overweight and obese were associated with increased prevalence of atopic dermatitis in Asia and North America (OR 1.23, 95% CI 1.11-1.41, and OR 1.47, 95% CI 1.21-1.79, respectively) [
         <a href="#rid148">
          148
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         However, the mechanisms underlying this association are largely unknown.
        </p>
        <p class="headingAnchor" id="H1156419074">
         <span class="h2">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Previous studies evaluating the association between atopic dermatitis and cardiovascular disease provided conflicting evidence.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2018 large population-based study using 1998 to 2015 data from the United Kingdom Clinical Practice Research Datalink compared the data from nearly 400,000 adult patients with atopic dermatitis and 1.5 million controls matched by age, sex, calendar time, and age and date at cohort entry [
         <a href="#rid149">
          149
         </a>
         ]. This study found that patients with atopic dermatitis and, in particular, those with severe disease (as defined by treatment with systemic immunosuppressants, phototherapy, or specialist referral) had a modest increase in the risk of cardiovascular disease, including myocardial infarction (HR 1.37, 95% CI 1.12-1.68), unstable angina (HR 1.41, 95% CI 1.02-1.95), heart failure (HR 1.67, 95% CI 1.36-2.05), atrial fibrillation (HR 1.35, 95% CI 1.14-1.59), and cardiovascular death (HR 1.30, 95% CI 1.10-1.53). Although known confounding factors (eg, body mass index, smoking, hypertension, hyperlipidemia, diabetes) had been adjusted for, the possibility that the results were driven by residual confounding cannot be excluded. In addition, this study could not determine whether atopic dermatitis per se or treatments for atopic dermatitis confer an increased risk of cardiovascular disease. Despite these caveats, this study indicates that in adults presenting with severe atopic dermatitis, screening for cardiovascular disease and known risk factors for cardiovascular disease may be appropriate.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2017 cross-sectional analysis of data from the Canadian Partnership for Tomorrow Project including nearly 260,000 Canadian residents aged 30 to 74 years, of whom approximately 21,000 had a history of atopic dermatitis, found that atopic dermatitis was associated with a mild reduction in the risk of hypertension (OR 0.87, 95% CI 0.83-0.90), type 2 diabetes (OR 0.78, 95% CI 0.71-0.84), myocardial infarction (OR 0.87, 95% CI 0.75-1.00), and stroke (OR 0.79, 95% CI 0.66-0.95), after adjusting for age, sex, ethnic background, body mass index, smoking 100 cigarettes, weekly alcohol intake, average daily sleep, and weekly physical activity [
         <a href="#rid150">
          150
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2017 meta-analysis using adjusted data from 13 studies did not find an association between atopic dermatitis and myocardial infarction (pooled OR 1.03, 95% CI 0.88-1.21), stroke (OR 1.12, 95% CI 0.95-1.32), or hypertension (OR 1.10, 95% CI 0.97-1.24) but found a nearly 50 percent increased risk of angina pectoris (OR 1.48, 95% CI 1.23-1.79) [
         <a href="#rid151">
          151
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1208373967">
         <span class="h2">
          Anemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         An analysis of caregiver-reported and self-reported data on over 200,000 children and adolescents from the 1997 to 2013 United States National Health Interview Survey found that children with a history of atopic disorders, including eczema, asthma, hay fever, or food allergy, have an increased risk of anemia (for eczema, OR 1.83, 95% CI 1.58-2.13) [
         <a href="#rid152">
          152
         </a>
         ]. The risk was much higher in children with all four disorders (adjusted OR 7.87, 95% CI 5.17-12). Using laboratory data from the 2014 to 2015 National Health and Nutrition Examination Survey on over 30,000 children, the authors found that children with a current history of atopic eczema had a twofold increased risk of anemia, particularly microcytic anemia (OR 2.03, 95% CI 1.20-3.46).
        </p>
        <p>
         Whether anemia in children with atopic dermatitis is related to chronic inflammation or malnutrition secondary to dietary restrictions in patients suspected to have food allergies is unknown. Further ad hoc-designed studies are needed to confirm this association and clarify the underlying mechanisms.
        </p>
        <p class="headingAnchor" id="H406735829">
         <span class="h1">
          RISK OF CANCER
         </span>
        </p>
        <p class="headingAnchor" id="H3139836036">
         <span class="h2">
          Lymphoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         The association between atopic dermatitis and lymphoma remains controversial [
         <a href="#rid153">
          153,154
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2015 systematic review and meta-analysis of 4 cohort studies and 18 case-control studies found a modest increase in the risk of lymphoma in patients with atopic dermatitis compared with the general population [
         <a href="#rid155">
          155
         </a>
         ]. The risk increase was significant in the meta-analysis of the cohort studies (relative risk [RR] 1.43, 95% CI 1.12-1.81) but not in the case-control studies (odds ratio [OR] 1.18, 95% CI 0.94-1.47). However, the large heterogeneity of case-control studies in study design and diagnostic criteria does not allow any definite conclusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Three of the studies included in this meta-analysis reported a significant association between severity of atopic dermatitis and cutaneous T cell lymphoma (CTCL) [
         <a href="#rid156">
          156-158
         </a>
         ]. However, this finding must be interpreted with caution because a misclassification bias cannot be excluded. Due to overlapping clinical features, CTCL cases may have initially been misdiagnosed and treated as severe atopic dermatitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2023 United Kingdom study that included a pediatric cohort of 409,431 children with atopic dermatitis and 1,809,029 children without atopic dermatitis aged four to nine years followed for a median follow-up time of five to seven years found that the overall risk of hematologic malignancies was not different in the two groups (hazard ratio [HR] 1.07, 95% CI 0.91-1.25) [
         <a href="#rid159">
          159
         </a>
         ]. However, among children with severe atopic dermatitis, there was a statistically significant greater risk of all noncutaneous lymphomas (HR 3.18, 95% CI 1.41-7.16).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In the adult cohort that included 625,083 patients with atopic dermatitis and 2,678,888 patients without atopic dermatitis, patients with moderate or severe disease had a slightly increased risk of all hematologic malignancies (HR 1.09, 95% CI 1.03-1.14; and HR 1.44, 95% CI 1.27-1.64, respectively), mainly driven by lymphomas. In particular, the risk of CTCL increased with worsening severity of atopic dermatitis (HR 1.73, 95% CI 1.21-2.47; HR 5.60, 95% CI 4.34-7.23; and HR 18.09, 95% CI 12.43-26.32 for mild, moderate, and severe disease, respectively). An increased risk of CTCL was found in all severity categories after excluding patients receiving systemic immunosuppressive treatments.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H641014912">
         <span class="h2">
          Skin cancer and other cancers
         </span>
         <span class="headingEndMark">
          —
         </span>
         The association of atopic dermatitis with skin cancer and internal cancers is controversial.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2020 systematic review and meta-analysis of eight population-based, cohort studies (n = 5,726,692) found among patients with atopic dermatitis a higher incidence rate of keratinocyte carcinomas (five studies, pooled standardized incidence ratio [SIR] 1.46, 95% CI 1.20-1.77) and cancers of the kidney (two studies, pooled SIR 1.86, 95% CI 1.14-3.04), central nervous system (two studies, pooled SIR 1.81, 95% CI 1.22-2.70), and pancreas (one study, SIR 1.90, 95% CI 1.03-3.50) [
         <a href="#rid160">
          160
         </a>
         ]. However, the authors concluded that because of methodologic and quality heterogeneity across the included studies and variation in the definition of atopic dermatitis, no firm conclusions can be drawn about these associations. Moreover, detection bias, due to increased medical surveillance of patients with atopic dermatitis, cannot be excluded.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast, two large, cohort studies performed in England (471,970 individuals with atopic eczema and 2,239,775 without atopic eczema) and Denmark (44,945 individuals with atopic eczema and 445,673 without atopic eczema) did not find an association between atopic dermatitis and overall risk of cancer [
         <a href="#rid161">
          161
         </a>
         ]. However, in the English cohort, individuals with atopic dermatitis had a 20 percent higher risk of non-Hodgkin lymphoma (HR 1.20, 99% CI 1.07-1.34) and a nearly 50 percent higher risk of Hodgkin lymphoma (HR 1.48, 99% CI 1.07-2.04). A similar increased risk of non-Hodgkin lymphoma and Hodgkin lymphoma, although nonstatistically significant, was found in the Danish cohort.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H4271554058">
         <span class="h2">
          History and clinical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the vast majority of cases, the diagnosis of atopic dermatitis is clinical, based upon history, morphology and distribution of skin lesions, and associated clinical signs  (
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Common features'
         </a>
         above and
         <a class="local">
          'Associated features'
         </a>
         above.)
        </p>
        <p>
         Because of the high variability of clinical presentation, related to age, ethnicity, and severity, the diagnosis may be difficult, especially in infants and older adults. Moreover, in patients with highly pigmented skin, the clinical signs of dermatitis differ from those seen in patients with light skin types [
         <a href="#rid162">
          162
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dry skin may appear whitish or ashy color  (
         <a class="graphic graphic_picture graphicRef101381" href="/z/d/graphic/101381.html" rel="external">
          picture 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erythema may appear violaceous or may not be visible at all  (
         <a class="graphic graphic_picture graphicRef56815" href="/z/d/graphic/56815.html" rel="external">
          picture 1C
         </a>
         ). Presence of edema or scale and increased skin temperature to the touch are signs of underlying erythema and inflammation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lichenified areas from chronic scratching may appear hyperpigmented  (
         <a class="graphic graphic_picture graphicRef116283" href="/z/d/graphic/116283.html" rel="external">
          picture 3A
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postinflammatory hyper- and hypopigmentation are common  (
         <a class="graphic graphic_picture graphicRef116284" href="/z/d/graphic/116284.html" rel="external">
          picture 3B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1147856168">
         <span class="h2">
          Diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several sets of criteria have been proposed for the diagnosis of atopic dermatitis. Although they are generally used in epidemiologic studies, they provide guidance to the diagnostic approach in clinical settings.
        </p>
        <p>
         The United Kingdom Working Group on atopic dermatitis criteria include one mandatory and five major criteria but do not include allergy criteria as originally proposed by Hanifin and Rajka [
         <a href="#rid163">
          163,164
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence of pruritic skin, including the report by a parent or caregiver of a child rubbing or scratching
        </p>
        <p>
        </p>
        <p>
         In addition to itchy skin, three or more of the following are needed to make the diagnosis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of skin creases being involved. These include antecubital fossae, popliteal fossae, neck, areas around eyes, and fronts of ankles.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of asthma or hay fever (or history of atopic disease in a first-degree relative for children &lt;4 years of age).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of generally dry skin within the past year.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptoms beginning in a child before the age of two years. This criterion is not used to make the diagnosis in a child who is under four years old.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Visible dermatitis involving flexural surfaces. For children under four years of age, this criterion is met by dermatitis affecting the cheeks or forehead and outer aspects of the extremities. (See
         <a class="local">
          'Common features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         The American Academy of Dermatology criteria for the diagnosis of atopic dermatitis include three sets of essential, important, and associated features [
         <a href="#rid2">
          2,165
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Essential features (any three required)
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mild to severe pruritus
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Eczema (acute, subacute, chronic) with typical morphology and age-specific patterns:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Facial, neck, and extensor involvement in infants and children up to four years of age
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Current or previous flexural lesions in any age group
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic or relapsing course
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Important features (two or more required)
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Onset before two years of age
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Personal and/or family history of allergic rhinitis, asthma, food allergies, or atopic dermatitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dry skin within the last year
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated features (one or more required)
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Atypical, vascular responses (eg, facial pallor, white dermographism, delayed blanch response)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Keratosis pilaris, pityriasis alba, hyperlinear palms, ichthyosis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Periocular changes (periorbital darkening or lichenification, bilateral periorbital eczema, Dennie-Morgan lines under the lower eyelids)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perioral eczema, bilateral periauricular eczema lesions, prurigo nodules or papules
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perifollicular accentuation or lichenification
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sparing of groin or axilla
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H948904556">
         <span class="h2">
          Skin biopsy and laboratory tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Skin biopsy and laboratory testing, including IgE levels, are
         <strong>
          not
         </strong>
         used routinely in the evaluation of patients with suspected atopic dermatitis and are not recommended. However, in selected patients, histologic examination of a skin biopsy or other laboratory tests (eg, serum IgE, potassium hydroxide preparation, patch testing, genetic testing) may be helpful to rule out other skin conditions [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of atopic dermatitis includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Allergic or irritant contact dermatitis
         </strong>
         – Allergic or irritant contact dermatitis may be difficult to differentiate from atopic dermatitis  (
         <a class="graphic graphic_picture graphicRef51066" href="/z/d/graphic/51066.html" rel="external">
          picture 15
         </a>
         ). Moreover, allergic contact dermatitis may coexist with atopic dermatitis [
         <a href="#rid166">
          166,167
         </a>
         ]. The localization of dermatitis to a specific skin area, history of exposure to irritants or potential sensitizers, and a relevant patch test positivity suggest the diagnosis of contact dermatitis. A skin biopsy is not useful to distinguish irritant or allergic contact dermatitis from atopic dermatitis, as they share identical histopathologic features. (See
         <a class="medical medical_review" href="/z/d/html/13655.html" rel="external">
          "Clinical features and diagnosis of allergic contact dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seborrheic dermatitis
         </strong>
         – Seborrheic dermatitis is the most common differential diagnosis in infants  (
         <a class="graphic graphic_picture graphicRef73813 graphicRef130273 graphicRef52803" href="/z/d/graphic/73813.html" rel="external">
          picture 16A-C
         </a>
         ). The two conditions may also coexist. The presence of salmon-red, erythematous skin patches with greasy scale, involvement of the scalp, and little or no pruritus support the diagnosis of seborrheic dermatitis. (See
         <a class="medical medical_review" href="/z/d/html/13669.html" rel="external">
          "Seborrheic dermatitis in adolescents and adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16261.html" rel="external">
          "Cradle cap and seborrheic dermatitis in infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psoriasis
         </strong>
         – In contrast with atopic dermatitis, in infants and young children, psoriasis often involves the diaper area, with well-demarcated, erythematous patches with little scale  (
         <a class="graphic graphic_picture graphicRef99441 graphicRef95639" href="/z/d/graphic/99441.html" rel="external">
          picture 17A-B
         </a>
         and
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5664.html" rel="external">
          "Psoriasis: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Scabies
         </strong>
         – Scabies may present as a diffuse eruption mimicking atopic dermatitis  (
         <a class="graphic graphic_picture graphicRef52588" href="/z/d/graphic/52588.html" rel="external">
          picture 18
         </a>
         ). The involvement of the skin folds (and, in infants, of the diaper area) and the presence of vesicopustules on the palms and soles suggest the diagnosis of scabies. The demonstration of mites or eggs by skin scraping, dermoscopy, or adhesive tape test can confirm the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/4038.html" rel="external">
          "Scabies: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Less common conditions that may be confused with atopic dermatitis include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Drug reactions  (
         <a class="graphic graphic_picture graphicRef54205" href="/z/d/graphic/54205.html" rel="external">
          picture 19
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/15762.html" rel="external">
          "Exanthematous (maculopapular) drug eruption"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Primary immunodeficiencies, including Wiskott-Aldrich syndrome  (
         <a class="graphic graphic_picture graphicRef95686" href="/z/d/graphic/95686.html" rel="external">
          picture 20
         </a>
         ) and hyperimmunoglobulin E syndrome  (
         <a class="graphic graphic_picture graphicRef61049" href="/z/d/graphic/61049.html" rel="external">
          picture 21
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3953.html" rel="external">
          "Wiskott-Aldrich syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3960.html" rel="external">
          "Autosomal dominant hyperimmunoglobulin E syndrome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nutritional deficiencies, acrodermatitis enteropathica  (
         <a class="graphic graphic_picture graphicRef71329" href="/z/d/graphic/71329.html" rel="external">
          picture 22
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5354.html" rel="external">
          "Zinc deficiency and supplementation in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Netherton syndrome  (
         <a class="graphic graphic_picture graphicRef87482 graphicRef87481" href="/z/d/graphic/87482.html" rel="external">
          picture 23A-B
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/15465.html" rel="external">
          "Overview and classification of the inherited ichthyoses", section on 'Netherton syndrome'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cutaneous T cell lymphoma (see
         <a class="medical medical_review" href="/z/d/html/1674.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3695164431">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112824.html" rel="external">
          "Society guideline links: Atopic dermatitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15392.html" rel="external">
          "Patient education: Eczema (atopic dermatitis) (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/7638.html" rel="external">
          "Patient education: Eczema (atopic dermatitis) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology and risk factors
         </strong>
         – Atopic dermatitis is a chronic, pruritic, inflammatory skin disease that occurs most frequently in children but also affects adults, with an estimated worldwide prevalence in children of 5 to over 20 percent. A family history of atopy (eczema, asthma, or allergic rhinitis) and the loss-of-function mutations in the filaggrin (
         <em>
          FLG
         </em>
         ) gene, involved in the skin barrier function, are major risk factors for atopic dermatitis. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – The cardinal features of atopic dermatitis are dry skin and severe pruritus. Erythema, papulation, oozing and crusting, excoriation, and lichenification vary with the patient's age, ethnicity, and stage of lesions  (
         <a class="graphic graphic_picture graphicRef56461 graphicRef55424 graphicRef68215" href="/z/d/graphic/56461.html" rel="external">
          picture 1A, 4B, 6C
         </a>
         and
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ). In children and adults with deeply pigmented skin, the typical erythematous and scaly lesions of eczema may appear with a grayish, violaceous, or dark brown hue  (
         <a class="graphic graphic_picture graphicRef68215 graphicRef116283 graphicRef102395 graphicRef56815" href="/z/d/graphic/68215.html" rel="external">
          picture 1A-C, 3A
         </a>
         ). (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of atopic dermatitis is clinical, based upon history, morphology and distribution of skin lesions, and associated clinical signs  (
         <a class="graphic graphic_figure graphicRef139793" href="/z/d/graphic/139793.html" rel="external">
          figure 1
         </a>
         ). Diagnostic criteria for the clinical diagnosis include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pruritus
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Eczema (acute, subacute, chronic) with typical morphology and age-specific patterns:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Facial, neck, and extensor involvement in infants and children
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Current or previous flexural lesions in any age group
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Sparing of the groin and axillary regions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic or relapsing history
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Skin biopsy and laboratory testing, including immunoglobulin E (IgE) levels, are usually not necessary in patients felt clinically to have atopic dermatitis. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H259574468">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges William L Weston, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 105:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006; 118:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009; 124:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenzie C, Silverberg JI. The prevalence and persistence of atopic dermatitis in urban United States children. Ann Allergy Asthma Immunol 2019; 123:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lloyd-Lavery A, Solman L, Grindlay DJC, et al. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors. Clin Exp Dermatol 2019; 44:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fu T, Keiser E, Linos E, et al. Eczema and sensitization to common allergens in the United States: a multiethnic, population-based study. Pediatr Dermatol 2014; 31:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinding GR, Zarchi K, Ibler KS, et al. Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm Venereol 2014; 94:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rönmark EP, Ekerljung L, Lötvall J, et al. Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden. Br J Dermatol 2012; 166:1301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mortz CG, Andersen KE, Dellgren C, et al. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy 2015; 70:836.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J Invest Dermatol 2019; 139:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deckers IA, McLean S, Linssen S, et al. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One 2012; 7:e39803.
          </a>
         </li>
         <li class="breakAll">
          Kang K, Polster AM, Nedorost St, et al. Atopic dermatitis. In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Mosby, 2003. p.199.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerner T, Haugaard JH, Vestergaard C, et al. Disease severity and trigger factors in Danish children with atopic dermatitis: a nationwide study. J Eur Acad Dermatol Venereol 2021; 35:948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandström MH, Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study. Br J Dermatol 2004; 150:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365:1315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339:b2433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paternoster L, Standl M, Waage J, et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 2015; 47:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schram ME, Tedja AM, Spijker R, et al. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol 2010; 162:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol 2013; 133:1752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flohr C, Yeo L. Atopic dermatitis and the hygiene hypothesis revisited. Curr Probl Dermatol 2011; 41:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005; 152:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNally NJ, Williams HC, Phillips DR, et al. Atopic eczema and domestic water hardness. Lancet 1998; 352:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyake Y, Yokoyama T, Yura A, et al. Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area. Environ Res 2004; 94:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnedo-Pena A, Bellido-Blasco J, Puig-Barbera J, et al. [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children]. Salud Publica Mex 2007; 49:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaumont A, Voisin C, Sardella A, Bernard A. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. Environ Res 2012; 116:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perkin MR, Craven J, Logan K, et al. Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A population-based cross-sectional study. J Allergy Clin Immunol 2016; 138:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jabbar-Lopez ZK, Ung CY, Alexander H, et al. The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysis. Clin Exp Allergy 2021; 51:430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsakok T, Woolf R, Smith CH, et al. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 2019; 180:464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ständer S. Atopic Dermatitis. N Engl J Med 2021; 384:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol 2019; 143:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elias PM, Wakefield JS. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 134:781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta 2014; 1841:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelleher M, Dunn-Galvin A, Hourihane JO, et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol 2015; 135:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung DY. Clinical implications of new mechanistic insights into atopic dermatitis. Curr Opin Pediatr 2016; 28:456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers 2018; 4:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drislane C, Irvine AD. The role of filaggrin in atopic dermatitis and allergic disease. Ann Allergy Asthma Immunol 2020; 124:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Regan GM, Sandilands A, McLean WHI, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122:1285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandner JM, Zorn-Kruppa M, Yoshida T, et al. Epidermal tight junctions in health and disease. Tissue Barriers 2015; 3:e974451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 127:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 2013; 62:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009; 124:R7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28:719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baurecht H, Irvine AD, Novak N, et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007; 120:1406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winge MC, Bilcha KD, Liedén A, et al. Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis. Br J Dermatol 2011; 165:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thawer-Esmail F, Jakasa I, Todd G, et al. South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin. J Allergy Clin Immunol 2014; 133:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margolis DJ, Mitra N, Gochnauer H, et al. Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans. J Invest Dermatol 2018; 138:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margolis DJ, Mitra N, Wubbenhorst B, et al. Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis. JAMA Dermatol 2019; 155:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin MJ, Estravís M, García-Sánchez A, et al. Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review. Genes (Basel) 2020; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heede NG, Thyssen JP, Thuesen BH, et al. Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol 2015; 72:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paternoster L, Savenije OEM, Heron J, et al. Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts. J Allergy Clin Immunol 2018; 141:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulick AR, Mansfield KE, Silverwood RJ, et al. Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort. Br J Dermatol 2021; 185:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Astolfi A, Cipriani F, Messelodi D, et al. Filaggrin Loss-of-Function Mutations Are Risk Factors for Severe Food Allergy in Children with Atopic Dermatitis. J Clin Med 2021; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elhaji Y, Sasseville D, Pratt M, et al. Filaggrin gene loss-of-function mutations constitute a factor in patients with multiple contact allergies. Contact Dermatitis 2019; 80:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang J, Mitra N, Hoffstad O, Margolis DJ. Association of Filaggrin Loss of Function and Thymic Stromal Lymphopoietin Variation With Treatment Use in Pediatric Atopic Dermatitis. JAMA Dermatol 2017; 153:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guttman-Yassky E, Suárez-Fariñas M, Chiricozzi A, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009; 124:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010; 125:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honda T, Kabashima K. Reconciling innate and acquired immunity in atopic dermatitis. J Allergy Clin Immunol 2020; 145:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcovich S, Maurelli M, Gisondi P, et al. Pruritus as a Distinctive Feature of Type 2 Inflammation. Vaccines (Basel) 2021; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014; 134:769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol Venereol 2020; 34:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oetjen LK, Mack MR, Feng J, et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell 2017; 171:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson EL, Bieber T, Guttman-Yassky E, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med 2016; 375:2335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruzicka T, Hanifin JM, Furue M, et al. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N Engl J Med 2017; 376:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship. Trends Microbiol 2018; 26:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Totté JE, van der Feltz WT, Hennekam M, et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016; 175:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22:850.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998; 351:1715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pugliarello S, Cozzi A, Gisondi P, Girolomoni G. Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges 2011; 9:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deleuran M, Vestergaard C. Clinical heterogeneity and differential diagnosis of atopic dermatitis. Br J Dermatol 2014; 170 Suppl 1:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Julián-Gónzalez RE, Orozco-Covarrubias L, Durán-McKinster C, et al. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol 2012; 29:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson EL, Thompson MM, Hanifin JM. Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis 2006; 17:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brans R, Hübner A, Gediga G, John SM. Prevalence of foot eczema and associated occupational and non-occupational factors in patients with hand eczema. Contact Dermatitis 2015; 73:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol 2014; 32:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulthanan K, Samutrapong P, Jiamton S, Tuchinda P. Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. Asian Pac J Allergy Immunol 2007; 25:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams HC, Strachan DP. The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 1998; 139:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burr ML, Dunstan FD, Hand S, et al. The natural history of eczema from birth to adult life: a cohort study. Br J Dermatol 2013; 168:1339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garmhausen D, Hagemann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013; 68:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorsteinsdottir S, Stokholm J, Thyssen JP, et al. Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood. JAMA Dermatol 2019; 155:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. J Am Acad Dermatol 2016; 75:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matiz C, Tom WL, Eichenfield LF, et al. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience. Pediatr Dermatol 2011; 28:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balma-Mena A, Lara-Corrales I, Zeller J, et al. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int J Dermatol 2011; 50:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123:e808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seegräber M, Worm M, Werfel T, et al. Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients. J Eur Acad Dermatol Venereol 2020; 34:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung DY. Why is eczema herpeticum unexpectedly rare? Antiviral Res 2013; 98:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Kobyletzki LB, Bornehag CG, Hasselgren M, et al. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol 2012; 12:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bantz SK, Zhu Z, Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol 2014; 5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eigenmann PA, Calza AM. Diagnosis of IgE-mediated food allergy among Swiss children with atopic dermatitis. Pediatr Allergy Immunol 2000; 11:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García C, El-Qutob D, Martorell A, et al. Sensitization in early age to food allergens in children with atopic dermatitis. Allergol Immunopathol (Madr) 2007; 35:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paller AS, Mina-Osorio P, Vekeman F, et al. Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence. J Am Acad Dermatol 2022; 86:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101:E8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray CL, Levin ME, Zar HJ, et al. Food allergy in South African children with atopic dermatitis. Pediatr Allergy Immunol 2014; 25:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eller E, Kjaer HF, Høst A, et al. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy 2009; 64:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kvenshagen B, Jacobsen M, Halvorsen R. Atopic dermatitis in premature and term children. Arch Dis Child 2009; 94:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spergel JM, Boguniewicz M, Schneider L, et al. Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements. Pediatrics 2015; 136:e1530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan J, Mitra N, Hoffstad OJ, et al. Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study. J Am Acad Dermatol 2017; 77:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tran MM, Lefebvre DL, Dharma C, et al. Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study. J Allergy Clin Immunol 2018; 141:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lowe AJ, Leung DYM, Tang MLK, et al. The skin as a target for prevention of the atopic march. Ann Allergy Asthma Immunol 2018; 120:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dharmage SC, Lowe AJ, Matheson MC, et al. Atopic dermatitis and the atopic march revisited. Allergy 2014; 69:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartnikas LM, Gurish MF, Burton OT, et al. Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. J Allergy Clin Immunol 2013; 131:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 2014; 134:867.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol 2015; 135:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers JR, Haines RH, Mitchell EJ, et al. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial. Trials 2017; 18:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014; 134:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kortekaas Krohn I, Badloe FMS, Herrmann N, et al. Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march. Allergy 2023; 78:3178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weidinger S, O'Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008; 121:1203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bremmer SF, Hanifin JM, Simpson EL. Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: implications for allergic respiratory disease and prognosis. J Am Acad Dermatol 2008; 59:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tay YK, Kong KH, Khoo L, et al. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 2002; 146:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol 2014; 70:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pattnaik L, Acharya L. A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sci 2015; 128:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 2011; 128:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan J, Mitra N, Hooper SR, et al. Association of Atopic Dermatitis Severity With Learning Disability in Children. JAMA Dermatol 2021; 157:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radtke S, Grossberg AL, Wan J. Mental health comorbidity in youth with atopic dermatitis: A narrative review of possible mechanisms. Pediatr Dermatol 2023; 40:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen MH, Su TP, Chen YS, et al. Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study. J Psychosom Res 2014; 77:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shyu CS, Lin HK, Lin CH, Fu LS. Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study. J Microbiol Immunol Infect 2012; 45:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 2010; 65:1506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strom MA, Fishbein AB, Paller AS, Silverberg JI. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br J Dermatol 2016; 175:920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fan R, Leasure AC, Damsky W, Cohen JM. Association of atopic dermatitis with attention-deficit hyperactivity disorder among US adults in the "All of Us" research program: A case-control study. J Am Acad Dermatol 2022; 87:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010; 64:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buske-Kirschbaum A, Schmitt J, Plessow F, et al. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 2013; 38:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng CM, Hsu JW, Huang KL, et al. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord 2015; 178:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bao Q, Chen L, Lu Z, et al. Association between eczema and risk of depression: A systematic review and meta-analysis of 188,495 participants. J Affect Disord 2018; 238:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rønnstad ATM, Halling-Overgaard AS, Hamann CR, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. J Am Acad Dermatol 2018; 79:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandhu JK, Wu KK, Bui TL, Armstrong AW. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol 2019; 155:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel KR, Immaneni S, Singam V, et al. Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis. J Am Acad Dermatol 2019; 80:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Treudler R, Zeynalova S, Riedel-Heller SG, et al. Depression, anxiety and quality of life in subjects with atopic eczema in a population-based cross-sectional study in Germany. J Eur Acad Dermatol Venereol 2020; 34:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singhal A, Ross J, Seminog O, et al. Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med 2014; 107:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thyssen JP, Hamann CR, Linneberg A, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy 2018; 73:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Becker L, Kwasny M, et al. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol 2015; 151:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol 2011; 127:1180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol 2012; 166:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kusunoki T, Morimoto T, Nishikomori R, et al. Obesity and the prevalence of allergic diseases in schoolchildren. Pediatr Allergy Immunol 2008; 19:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luo X, Xiang J, Dong X, et al. Association between obesity and atopic disorders in Chinese adults: an individually matched case-control study. BMC Public Health 2013; 13:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis DMR, Drucker AM, Alikhan A, et al. American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol 2022; 86:1335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol 2015; 72:606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverwood RJ, Forbes HJ, Abuabara K, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ 2018; 361:k1786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drucker AM, Qureshi AA, Dummer TJB, et al. Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project. Br J Dermatol 2017; 177:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thyssen JP, Halling-Overgaard AS, Andersen YMF, et al. The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2018; 178:1272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drury KE, Schaeffer M, Silverberg JI. Association Between Atopic Disease and Anemia in US Children. JAMA Pediatr 2016; 170:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arana A, Wentworth CE, Fernández-Vidaurre C, et al. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163:1036.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res 2009; 69:6482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Legendre L, Barnetche T, Mazereeuw-Hautier J, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol 2015; 72:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arellano FM, Wentworth CE, Arana A, et al. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007; 127:808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arellano FM, Arana A, Wentworth CE, et al. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 2009; 123:1111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margolis D, Bilker W, Hennessy S, et al. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan J, Shin DB, Syed MN, et al. Malignancy risk in patients with atopic dermatitis: a population-based cohort study. Br J Dermatol 2023; 189:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang L, Bierbrier R, Drucker AM, Chan AW. Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis. JAMA Dermatol 2020; 156:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansfield KE, Schmidt SAJ, Darvalics B, et al. Association Between Atopic Eczema and Cancer in England and Denmark. JAMA Dermatol 2020; 156:1086.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol 2018; 27:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352:2314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Udkoff J, Borok J, Vaida F, et al. Assessment of the American Academy of Dermatology diagnostic criteria for pediatric atopic dermatitis and modification into a checkbox form: A cross-sectional study. Pediatr Dermatol 2023; 40:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simonsen AB, Johansen JD, Deleuran M, et al. Children with atopic dermatitis may have unacknowledged contact allergies contributing to their skin symptoms. J Eur Acad Dermatol Venereol 2018; 32:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Hou A, Warshaw EM, et al. Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016. J Allergy Clin Immunol Pract 2021; 9:2853.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1729 Version 59.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20674819" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : From atopic dermatitis to asthma: the atopic march.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24290431" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16815157" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : How epidemiology has challenged 3 prevailing concepts about atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9893196" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004783" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20739951" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31128232" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The prevalence and persistence of atopic dermatitis in urban United States children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30706503" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24283549" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Eczema and sensitization to common allergens in the United States: a multiethnic, population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24217962" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Is adult atopic eczema more common than we think? - A population-based study in Danish adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22372948" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25832131" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30389491" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22808063" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22808063" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33078461" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Disease severity and trigger factors in Danish children with atopic dermatitis: a nationwide study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14746623" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21991953" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Filaggrin mutations associated with skin and allergic diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19589816" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19501237" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26482879" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20331459" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Is there a rural/urban gradient in the prevalence of eczema? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23334343" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Climatic factors are associated with childhood eczema prevalence in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21576944" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Atopic dermatitis and the hygiene hypothesis revisited.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15727630" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9716057" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Atopic eczema and domestic water hardness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14643284" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17710278" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22591883" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27241890" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A population-based cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33259122" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374259" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The cutaneous innate immune response in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21682749" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29969827" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Atopic dermatitis: the skin barrier and beyond.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33761208" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30612663" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Atopic dermatitis endotypes and implications for targeted therapeutics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25131691" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24262790" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Role of lipids in the formation and maintenance of the cutaneous permeability barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25618747" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27191525" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Clinical implications of new mechanistic insights into atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29930242" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31622670" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The role of filaggrin in atopic dermatitis and allergic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18774165" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Filaggrin in atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19386895" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Filaggrin in the frontline: role in skin barrier function and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25838981" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Epidermal tight junctions in health and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21163515" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Tight junction defects in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23712284" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : New insights into atopic dermatitis: role of skin barrier and immune dysregulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19720210" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Cytokine modulation of atopic dermatitis filaggrin skin expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16815158" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3760273" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8496415" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16550169" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16444271" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17980411" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21692775" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24369804" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29428354" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31365035" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32325630" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25659224" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Anatomical patterns of dermatitis in adult filaggrin mutation carriers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29129583" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33655501" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33440636" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Filaggrin Loss-of-Function Mutations Are Risk Factors for Severe Food Allergy in Children with Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30868611" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Filaggrin gene loss-of-function mutations constitute a factor in patients with multiple contact allergies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27902816" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Association of Filaggrin Loss of Function and Thymic Stromal Lymphopoietin Variation With Treatment Use in Pediatric Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004782" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20109730" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : An update on the genetics of atopic dermatitis: scratching the surface in 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32109456" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Reconciling innate and acquired immunity in atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33807098" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Pruritus as a Distinctive Feature of Type 2 Inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25282559" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31566796" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Neuroimmune interactions in chronic itch of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28890086" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27690741" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28249150" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29233606" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26994362" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22310478" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9734903" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21054785" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Phenotypes of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24720512" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Clinical heterogeneity and differential diagnosis of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22469300" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Less common clinical manifestations of atopic dermatitis: prevalence by age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16956463" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Prevalence and morphology of hand eczema in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25716740" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Prevalence of foot eczema and associated occupational and non-occupational factors in patients with hand eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24314387" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Periorbital (eyelid) dermatides.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18402293" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9892950" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : The natural history of childhood eczema: observations from the British 1958 birth cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23301666" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The natural history of eczema from birth to adult life: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23452057" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Characterization of different courses of atopic dermatitis in adolescent and adult patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30427975" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27544489" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21070347" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21595661" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19403473" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31733162" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23439082" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Why is eczema herpeticum unexpectedly rare?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22839963" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25419479" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10893011" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Diagnosis of IgE-mediated food allergy among Swiss children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17338897" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Sensitization in early age to food allergens in children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34756933" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9481027" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Prevalence of IgE-mediated food allergy among children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25201137" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Food allergy in South African children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19220211" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Food allergy and food sensitization in early childhood: results from the DARC cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18829619" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Atopic dermatitis in premature and term children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26598458" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28818439" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29153857" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29413338" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The skin as a target for prevention of the atopic march.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24117677" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Atopic dermatitis and the atopic march revisited.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374269" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25282568" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25457149" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28732519" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25282563" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25282564" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Application of moisturizer to neonates prevents development of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37489049" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18396323" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Filaggrin mutations, atopic eczema, hay fever, and asthma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18455261" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: implications for allergic respiratory disease and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11841373" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24342754" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Atopic keratoconjunctivitis: A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25744396" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23245818" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Mental health comorbidity in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21684588" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16893440" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33851961" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Association of Atopic Dermatitis Severity With Learning Disability in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37665064" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Mental health comorbidity in youth with atopic dermatitis: A narrative review of possible mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25280829" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22580087" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20716320" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27105659" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35283246" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Association of atopic dermatitis with attention-deficit hyperactivity disorder among US adults in the "All of Us" research program: A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19692717" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23141851" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25795537" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29929155" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Association between eczema and risk of depression: A systematic review and meta-analysis of 188,495 participants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30119868" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30540348" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30365995" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31838777" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Depression, anxiety and quality of life in subjects with atopic eczema in a population-based cross-sectional study in Germany.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24526464" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28632893" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25536049" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Central obesity and high blood pressure in pediatric patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21411132" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Association between obesity and atopic dermatitis in childhood: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21999468" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Association between atopic dermatitis and obesity in adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18221473" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Obesity and the prevalence of allergic diseases in schoolchildren.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23297741" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Association between obesity and atopic disorders in Chinese adults: an individually matched case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35085682" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25773409" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29792314" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28617976" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29210061" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26619045" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Association Between Atopic Disease and Anemia in US Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20545690" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654312" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25840730" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17096020" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19361841" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11405770" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : The risk of malignancy associated with psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37418646" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Malignancy risk in patients with atopic dermatitis: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31825457" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32579178" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Association Between Atopic Eczema and Cancer in England and Denmark.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29457272" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15930422" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Clinical practice. Atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7918017" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37341972" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Assessment of the American Academy of Dermatology diagnostic criteria for pediatric atopic dermatitis and modification into a checkbox form: A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29222945" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Children with atopic dermatitis may have unacknowledged contact allergies contributing to their skin symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33781959" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
